|
|
| ÍÂ | 9 |  | 4.84 |
| pseudoephedrine 8Í | 5 | | 2.69 |
| ÂÒºÓÃا¼ÊÁä«â»Ã | 3 | | 1.61 |
| ˹ѧÊ×͡ӨѴàÁÕ¹éÍÂãËéÍÂÙèËÁÑ´ | 3 | | 1.61 |
| áÍÁâÁà¹Õ·Õè¢ÒÂã¹µÅÒ´ | 3 | | 1.61 |
| Çѵ¶Ø·ÕèÍÒ¨ãªéã¹à¤Ã×èͧÊÓÍÒ§ | 3 | | 1.61 |
| áÍÊä¾ÃÔ¹á¡é¤Ñ¹ä´äËÁ | 2 | | 1.08 |
| â«áÅÁ ¤×Í | 2 | | 1.08 |
| ÂÒʵÃÕºÑÇá¡éÇẺàÁç´ | 2 | | 1.08 |
| âËÂè§àËÔ§ | 2 | | 1.08 |
| ÂÒ ors | 2 | | 1.08 |
| ÈÙ¹ÂìÇԷºÃÔ¡ÒÃÊíҹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ | 2 | | 1.08 |
| ¡ÒûÃѺ¤èҵͺ᷹¾¹Ñ¡§Ò¹ÃÒª¡ÒÃ15000¡ÃзÃǧÊÒ¸ÒóÊØ¢ | 2 | | 1.08 |
| ¤ÃÕÁ»ÃзԹ¼ÔÇbest beautyËÒ«×éÍä´é·Õèä˹ | 2 | | 1.08 |
| ÍÂ.¢Òµç | 2 | | 1.08 |
| ¼Å´Õ ¼ÅàÊÕ¢ͧ¡ÅÙ | 2 | | 1.08 |
| ¢Ñ鹵͹¡ÒâÍ͹ØÒµ ¹Óà¢éÒÍÒËÒà | 2 | | 1.08 |
| pic/s ÍÂ | 2 | | 1.08 |
| ÂÒʵÃÕºÑÇá¡éÇ ÊÃþ¤Ø³ | 2 | | 1.08 |
| ¼ÅÔµÀѳ±ìá»êСêÇ | 2 | | 1.08 |
| ÂÒá¡é»Ç´áººá¼è¹á»Ð (transdermal fentanyl) ÁÕ¢Ò·Õèä˹ | 2 | | 1.08 |
| ÃÒ¡ÒÃÂÒà¾çªÃÃѵ¹ìàÀÊѪ ÈÔÃÔÃÒª | 2 | | 1.08 |
| ÇÔ¸Õ·Óà¹Â¶ÑèÇ | 2 | | 1.08 |
| ªÓ¹Ò ÀÙèàÍÕèÂÁ ºÃóҹءÃÁ | 2 | | 1.08 |
| ÂÒÅÐÅÒÂÅÔèÁàÅ×Í´ | 2 | | 1.08 |
| ¢Ñ鹵͹ ¡ÒÃÊè§ÍÍ¡ ÂÒÊѵÇì | 2 | | 1.08 |
| ÂÒʵÃÕËÁÍÁÕ | 1 | | 0.54 |
| ÁÙŹԸԵ§ÎÑéÇ¡ÒÃá¾·Âì ¸¹ºØÃÕ | 1 | | 0.54 |
| áËÅ觢Ò¼§¡Ãͺ | 1 | | 0.54 |
| ¡ÅÙµéÒä¸â͹ ÃÑ¡ÉÒÁÐàÃç§ | 1 | | 0.54 |
| ÈÙ¹ÂìÇԷºÃÔ¡Òà | 1 | | 0.54 |
| ÂÕèËéÍÂÒá¡éä¢éËÇÑ´ | 1 | | 0.54 |
| ÂÒ·Ò§à¾È¢Í§á¤¹¹Ò´Ò | 1 | | 0.54 |
| âËÂè§àËÔ§ à¨ÃÔâÍʶ | 1 | | 0.54 |
| ÍÒËÒÃ ÂÒÇÒÃì¿ÒÃÔ¹ | 1 | | 0.54 |
| ´Ô¾à·ÍàÃç¡«ì | 1 | | 0.54 |
| ¡ÒÃãªéÂÒáÅÐÊÒÃà¤ÁÕ㹿ÒÃìÁ¡Øé§_ | 1 | | 0.54 |
| floctafenine ¡ÒÃÍÍ¡Ä·¸Ôì | 1 | | 0.54 |
| methylphenidate ¢¹Ò´ºÃÃ¨Ø | 1 | | 0.54 |
| ÂÒʵÃÕà¾çÀÒ¤ ÊÃþ¤Ø³ | 1 | | 0.54 |
| lang yi hao 125 mg | 1 | | 0.54 |
| Ä·¸Ôì¢Í§¡ÒáԹ¡ÃзèÍÁ | 1 | | 0.54 |
| panbesy ·ÐàºÕ¹ÂÒ | 1 | | 0.54 |
| ÇÔà¤ÃÒÐËì¨Ø´á¢ç§¨Ø´Íè͹¡ÒúԹä·Â | 1 | | 0.54 |
| sulfamethazine ¤×Í | 1 | | 0.54 |
| â·É¡ÒÃâ¦É³ÒªÇ¹àª×èèÍ | 1 | | 0.54 |
| ¹éÓá¢ç§ »ÃСÒÈ¡ÃзÃǧ | 1 | | 0.54 |
| Áҵðҹ gmp ¼ÅÔµÀѳ±ì¨Ò¡à¹×éÍÊѵÇì+ÍǪ. | 1 | | 0.54 |
| ¤ÃÕÁ cta | 1 | | 0.54 |
| ÊÔ¹¤éÒ·Õèµéͧ¼èÒ¹´èÒ¹ÍÒËÒÃáÅÐÂÒ | 1 | | 0.54 |
| »ÃÐàÀ·¢Í§ÂÒªÒ | 1 | | 0.54 |
| diclofenac fenoprofen ¤×Í | 1 | | 0.54 |
| à¡Å×ÍáÃè¡ÓÁжѹ | 1 | | 0.54 |
| ¡ÒõÃǨÊͺ¡Ãлëͧ¹éÓÁѹ | 1 | | 0.54 |
| ÂÒá¡é»Ç´áººá¼è¹á»Ð (transdermal fentanyl) ÁÕ¨Ó˹èÒ·Õèä˹ | 1 | | 0.54 |
| ¡Òû¹à»×é͹ ÍпÅÒ·Í¡«Ô¹ ÍѹµÃÒ¨ҡà¤ÁÕÊѧà¤ÃÒÐËì | 1 | | 0.54 |
| ÂÒÍÕ ¤×ÍÍÐäà | 1 | | 0.54 |
| ¢éÍ´Õ ¢éÍàÊÕ ¡ÅÙµéÒä¸â͹ | 1 | | 0.54 |
| ÂÒʵÃÕ¹ÔÊÔ§àË ¨ÍÁ·Í§ ¢éÍËéÒÁ | 1 | | 0.54 |
| ¢ÒÂÊÕ¼ÊÁÍÒËÒèҡ¸ÃÃÁªÒµÔ | 1 | | 0.54 |
| ÊÃþ¤Ø³ paracetamol | 1 | | 0.54 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢(©ºÑº·Õè 256) ¾.È. 2545 | 1 | | 0.54 |
| ª¹Ô´ ¢Í§ ÂÒ ªÒ | 1 | | 0.54 |
| ÂÒʵÃÕËÁÍÁÕ ´ÕäËÁ | 1 | | 0.54 |
| ÇÔ¸Õ·Ó¢Í Í. ÊÁعä¾Ã | 1 | | 0.54 |
| ÍÂ. | 1 | | 0.54 |
| ¼ÅàÊÕ¢ͧ¡ÅÙµéÒä¸â͹µèÍÃèÒ§¡Ò | 1 | | 0.54 |
| ÂÒʵÃÕູâÅÃÒ¤Ò¡ÕèºÒ· | 1 | | 0.54 |
| ¡Ô¹ÂÒʵÃÕËÁÍÁÕ | 1 | | 0.54 |
| swot ¢Í§ÊÒ¡ÒúԹ | 1 | | 0.54 |
| «ÍÊ»ÃاÃʤ×ÍÍÐäà | 1 | | 0.54 |
| ¸Ù»ËÍÁµÑͧ¼èÒ¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ? | 1 | | 0.54 |
| ÃéÒ¹¢ÒÂÂÒ˹éÒâç¾ÂÒºÒÅÃÒªÇÔ¶Õ | 1 | | 0.54 |
| ºÃÔÉÑ·¡ÒúԹä·Â swot | 1 | | 0.54 |
| ÃéÒ¹à¨êËÅÕ«ÍÂÈÃÕºØàÃ×ͧ | 1 | | 0.54 |
| ¡ÓÁжѹ ¼ÔÇ˹ѧ ¼Á | 1 | | 0.54 |
| «Ù¤ÃÒâÅÊ | 1 | | 0.54 |
| «Ùâ´ÍÕà¿´ÃÕ¹ | 1 | | 0.54 |
| ÃÒ¤ÒÂÒÃéÒ¹¢ÒÂÂÒ˹éÒâç¾ÂÒºÒÅÈÔÃÔÃÒª | 1 | | 0.54 |
| ¾Ãº ÂÒàʾµÔ´ 2530 | 1 | | 0.54 |
| «Ù¤ÃÒâÅ Ê «×éÍ | 1 | | 0.54 |
| ÃéÒ¹¢ÒÂÂÒ˹éÒâç¾ÂÒºÒŨØÌÒŧ¡Ã³ì | 1 | | 0.54 |
| ÇÔ¸Õ·Ó à¹Â¶ÑèÇ | 1 | | 0.54 |
| ¡ÒâÍ͹ØÒµ¼ÅÔµÊÁعä¾Ã | 1 | | 0.54 |
| ¡ÒÃÈÖ¡ÉÒÁҵáÒÃá¡é䢻ÑËÒ¡ÒÃÅÑ¡Åͺ¹Óà¢éÒ â€“ Êè§ÍÍ¡«Ùâ´ÍÕà¿´ÃÕ¹ (pseudoephedrine) µÓÃѺÂÒÊٵüÊÁ | 1 | | 0.54 |
| ¡ÒÃ¢Í Í¹éÓÊÁعä¾Ã | 1 | | 0.54 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 288 (¾.È. 2548) | 1 | | 0.54 |
| µÃǨ ÍÂ. ºÐËÁÕèÊÓàÃç¨ÃÙ» | 1 | | 0.54 |
| Áҵðҹ¡ÒüÅÔµ«ÍÊ | 1 | | 0.54 |
| ÂÒÊѵÇìẺ©Õ´ | 1 | | 0.54 |
| ÇÔ¸Õ ·Ó à¹Â ¶ÑèÇ | 1 | | 0.54 |
| à»ç¹ËÇÑ´¤Ñ´¨ÁÙ¡¤Ñ¹¤Í | 1 | | 0.54 |
| ÂÒá¡éä¢éËÇÑ´ | 1 | | 0.54 |
| ÍÒËÒà ˹éÒµÅÒ´¹¹·ì | 1 | | 0.54 |
| ¨Õéä½Ê¶ÒºÑ¹âä¼ÔÇ˹ѧ | 1 | | 0.54 |
| â«áÅÁ ¤×ÍÍÐäà | 1 | | 0.54 |
| ÂÒʵÃÕ¹ÔÊÔ§à˵ÃÒËÁÍÁÕ | 1 | | 0.54 |
| ºÑªÕÃÒª×èÍ Çѵ¶ØÍѹµÃÒª¹Ô´·Õè 1 fda | 1 | | 0.54 |
| â·É¢Í§¡ÒáԹá»êСêÇ | 1 | | 0.54 |
| »ÃСÒÈ ¡ÃзÃǧ ÊÒ¸ÒóÊØ¢ ©ºÑº ·Õè 135 2539 | 1 | | 0.54 |
,
User's Guide
˹éÒÅçÍ¡ÍÔ¹| ʶԵÔÃÒ»Õ
| ʶԵÔÃÒÂà´×͹
| ʶԵÔÃÒÂÇѹ
| ʶԵÔÃÒªÑèÇâÁ§
| Eng
Pageview 
Unique IPs 
Sessions